Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpizhenzhong is a Traditional Chinese Medicine (TCM) granule formulation developed by Dongzhimen Hospital, affiliated with the Beijing University of Chinese Medicine. It is specifically indicated for the treatment of chronic insomnia, particularly in patients presenting with the TCM syndrome of spleen deficiency and stomach disharmony (脾虚胃不和). The formulation is based on the classical TCM principle that digestive health is intrinsically linked to sleep quality, often summarized by the adage "if the stomach is disharmonious, sleep will be restless." By strengthening the spleen and harmonizing the stomach, Jianpizhenzhong aims to stabilize the mind and improve sleep architecture. It has been evaluated in clinical trials in China to assess its efficacy and safety as a potential alternative or adjunct to standard sedative-hypnotic therapies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jianpizhenzhong.